Pipeline — registered trials by phase
Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia
— · Congenital Bleeding Disorder, Haemophilia A, Haemophilia A With Inhibitors · Completed · est. 2014-10
Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle
— · Diabetes, Healthcare Professionals, Delivery Systems · Completed · est. 2005-04-26
Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)
— · Genetic Disorder, Noonan Syndrome · Completed · est. 2022-01-18
Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy
— · Menopause, Hormone Replacement Therapy, Post-Menopausal · Completed · est. 2006-06
Patient Preference Study in Type-2 Diabetes Mellitus: Discrete Choice Experiment (DCE) to Support Novo Nordisk's Long-Acting Insulin
— · Type-2 Diabetes Mellitus (T2DM) · Completed · est. 2024-04-29
A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2016-10-20
Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2011-11-01
A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists
— · Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD), Systemic Inflammation · Completed · est. 2024-05-10
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical Practice
— · Diabetes Mellitus, Type 2 · Completed · est. 2023-05-08
Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
— · Diabetes Mellitus, Type 2 · Not Yet Recruiting · est. 2027-08-30
Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2014-10-31
Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B
— · Congenital Bleeding Disorder, Haemophilia A, Haemophilia B · Completed · est. 2015-03
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice
— · Diabetes Mellitus, Type 2 · Completed · est. 2019-12-19
Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes
— · Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 · Completed · est. 2007-07
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
— · Diabetes Mellitus, Type 2 · Completed · est. 2021-07-19
Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2010-09
Glycaemic Control and Other Clinical Parameters in Adult Type 2 Diabetes Patients on Basal Insulin Initiating Treatment With IDegLira in Routine Clinical Practice in Colombia
— · Diabetes Mellitus, Type 2 · Completed · est. 2022-07-15
Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Type 1 Diabetes
— · Diabetes, Diabetes Mellitus, Type 1, Delivery Systems · Completed · est. 2011-03
An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes
— · Diabetes, Diabetes Mellitus, Type 1 · Completed · est. 2015-09
Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol
— · Haemophilia A · Enrolling By Invitation · est. 2026-12-01
Special Survey for Long Term Application
— · Genetic Disorder, Achondroplasia · Completed · est. 2007-03-31
Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2010-04
Post-marketing Surveillance (Use Result Surveillance) With Refixia®
— · Haemophilia B · Completed · est. 2025-09-30
A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics
— · Diabetes, Diabetes Mellitus, Type 1 · Completed · est. 2009-09
A Trial Evaluating the Blood Glucose-lowering Effect of NN1250 in Subjects With Type 2 Diabetes
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2010-11
A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-0499 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function
— · Non-alcoholic Steatohepatitis (NASH) · Completed · est. 2023-11-10
First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes
— · Healthy Volunteers, Overweight, Obesity · Completed · est. 2022-03-16
Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2004-03
A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney Problems
— · Diabetes Mellitus, Type 2 · Completed · est. 2019-09-06
Injection Site Pain Comparison of Excipient Solutions
— · Obesity · Completed · est. 2020-09-24
Study of DCR-A1AT in Healthy Adult Volunteers
— · Alpha 1-Antitrypsin Deficiency · Completed · est. 2021-07-06
A Study to Look at Safety and Tolerability of NNC0582-0001, How it is Transported Throughout the Body and How it Works in Healthy Adults
— · Healthy Volunteers · Completed · est. 2025-10-16
A Study to See How Safe a New Medicine (NNC6022-0001) is in Healthy People
— · Healthy Volunteers, Cardiometabolic Diseases · Completed · est. 2025-02-10
Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State
— · Congenital Bleeding Disorder, Haemophilia A, Haemophilia B · Completed · est. 2006-04
Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH
— · Diabetes, Healthy · Completed · est. 2007-04
Dose Response to Recombinant Factor VIIa When Administered for Bleed
— · Congenital Bleeding Disorder, Healthy · Completed · est. 2004-11
Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency
— · Congenital Bleeding Disorder, Congenital FXIII Deficiency · Completed · est. 2003-10
Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes
— · Diabetes, Diabetes Mellitus, Type 2, Delivery Systems · Completed · est. 2006-01
Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2007-10
Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid Arthritis
— · Inflammation, Rheumatoid Arthritis · Completed · est. 2013-10
A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men
— · Healthy Volunteers, Atherosclerotic Cardiovascular Disease · Completed · est. 2022-01-19
First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis
— · Inflammation, Rheumatoid Arthritis · Completed · est. 2013-06-17
A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency
— · Growth Hormone Disorder, Adult Growth Hormone Deficiency · Completed · est. 2013-11-18
Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus
— · Diabetes, Diabetes Mellitus, Type 1 · Completed · est. 2008-06
Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes
— · Diabetes, Diabetes Mellitus, Type 1 · Completed · est. 2001-06
A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.
— · Metabolism and Nutrition Disorder, Obesity · Completed · est. 2017-02-27
A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes
— · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 · Completed · est. 2022-07-20
A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens
— · Overweight, Obesity · Completed · est. 2020-10-20
Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage
— · Acquired Bleeding Disorder, Intracerebral Haemorrhage · Completed · est. 2003-03
A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity
— · Obesity · Completed · est. 2022-12-06
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2002-02
A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors
— · Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors · Completed · est. 2018-09-19
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
— · Primary Hyperoxaluria Type 1, End Stage Renal Disease · Recruiting · est. 2031-12-30
A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2009-02-05
Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
— · Alcohol-related Liver Disease · Completed · est. 2025-11-21
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
— · Congenital Bleeding Disorder, Haemophilia B · Completed · est. 2013-12-01
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
— · Diabetes, Diabetes Mellitus, Type 1 · Completed · est. 2006-05
A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2015-04
LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2018-05-04
Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors
— · Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors · Completed · est. 2012-08
Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2009-01
Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2004-07
Efficacy and Safety of Insulin Detemir in Type 1 Diabetes
— · Diabetes, Diabetes Mellitus, Type 1 · Completed · est. 2004-10-07
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes
— · Diabetes, Diabetes Mellitus, Type 1 · Completed · est. 2017-06-20
A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2019-06-14
Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes
— · Diabetes, Diabetes Mellitus, Type 1 · Completed · est. 2003-05-30
A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A
— · Congenital Bleeding Disorder, Haemophilia A · Completed · est. 2014-09-15
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2013-08-22
Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature
— · Growth Disorder, Idiopathic Short Stature · Completed · est. 2014-12-17
Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus
— · Diabetes, Diabetes Mellitus, Type 2 · Completed · est. 2017-08-19
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
— · Diabetes Mellitus, Type 2 · Completed · est. 2026-06-02
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
— · Obesity · Active Not Recruiting · est. 2028-08-28
STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
— · Metabolism and Nutrition Disorder, Overweight or Obesity · Completed · est. 2020-03-30
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
— · Cardiovascular Disease · Active Not Recruiting · est. 2027-09-01
LevemirInsulin Detemir
Source: ClinicalTrials.gov (trials where Novo Nordisk is lead sponsor; 84 active or completed) and Drugs@FDA (1 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 6-K2026-10-06Report of foreign issuer
- 6-K2026-10-05Report of foreign issuer
- 6-K2026-09-28Report of foreign issuer
- 6-K2026-09-21Report of foreign issuer
- 6-K2026-09-17Report of foreign issuer
- 6-K2026-09-15Report of foreign issuer
- 6-K2026-09-09Report of foreign issuer
- 6-K2026-08-31Report of foreign issuer
- 6-K2026-08-24Report of foreign issuer
- 6-K2026-08-18Report of foreign issuer
- 6-K2026-08-10Report of foreign issuer
- 6-K2026-08-10Report of foreign issuer
- 6-K2026-08-04Report of foreign issuer
- 6-K2026-08-04Report of foreign issuer
- 6-K2026-08-04Report of foreign issuer
- 6-K2026-07-31Report of foreign issuer
- 6-K2026-07-27Report of foreign issuer
- 6-K2026-07-21Report of foreign issuer
- 6-K2026-07-13Report of foreign issuer
- 6-K2026-07-06Report of foreign issuer
- 6-K2026-06-29Report of foreign issuer
- 6-K2026-06-24Report of foreign issuer
- SCHEDULE 13G/A2026-06-22SCHEDULE 13G/A
- 11-K2026-06-2211-K
- 11-K2026-06-2211-K
- 6-K2026-06-15Report of foreign issuer
- 6-K2026-06-08Report of foreign issuer
- 6-K2026-06-01Report of foreign issuer
- 6-K2026-05-27Report of foreign issuer
- 6-K2026-05-22Report of foreign issuer
- SD2026-05-22SD
- 6-K2026-05-22Report of foreign issuer
- 6-K2026-05-18Report of foreign issuer
- 6-K2026-05-13Report of foreign issuer
- 6-K2026-05-06Report of foreign issuer
- 6-K2026-05-05Report of foreign issuer
- 6-K2026-04-27Report of foreign issuer
- 6-K2026-04-20Report of foreign issuer
- 6-K2026-04-20Report of foreign issuer
- 6-K2026-04-13Report of foreign issuer
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.